Skip to main content
  1. Market Insights
  2. Health
  3. Mental Health

Psychotic Disorders - Africa

Africa
  • Revenue in the Psychotic Disorders market is projected to reach US$300.10m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.47%, resulting in a market volume of US$293.00m by 2029.
  • In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
  • In relation to total population figures, per person revenues of US$27.33 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

In-Scope

  • Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Out-Of-Scope

  • Psychotherapy
  • Talk therapy
  • Herbal medicines
  • Digital health apps
  • Deep Brain Stimulation (DBS)
Psychotic Disorders: market data & analysis - Cover

Market Insights report

Psychotic Disorders: market data & analysis

Study Details

    Revenue

    Notes: Data was converted from local currencies using average exchange rates of the respective year.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Patients

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Analyst Opinion

    The Psychotic Disorders market in Africa is experiencing significant growth and development.

    Customer preferences:
    Customers in Africa are increasingly seeking treatment for psychotic disorders, leading to a growing demand for medications and therapies. This can be attributed to several factors, including increased awareness and understanding of mental health issues, improved access to healthcare services, and reduced stigma surrounding mental illness. Additionally, the rising prevalence of psychotic disorders in the region is also driving the demand for effective treatment options.

    Trends in the market:
    One of the key trends in the Psychotic Disorders market in Africa is the increasing adoption of antipsychotic medications. These medications are commonly prescribed to manage symptoms such as hallucinations, delusions, and disorganized thinking. The growing availability and affordability of these medications, along with their proven efficacy, have contributed to their rising popularity among healthcare providers and patients in the region.Another trend in the market is the growing use of psychotherapy as a complementary treatment for psychotic disorders. Psychotherapy, including cognitive-behavioral therapy and family therapy, has been shown to be effective in reducing symptoms and improving overall functioning in individuals with psychotic disorders. As mental health services become more accessible in Africa, the demand for psychotherapy is expected to increase.

    Local special circumstances:
    In Africa, there are several unique circumstances that influence the development of the Psychotic Disorders market. One such circumstance is the limited availability and accessibility of mental healthcare services in many countries. This can be attributed to factors such as a shortage of mental health professionals, inadequate infrastructure, and limited funding for mental health programs. As a result, many individuals with psychotic disorders may not receive timely and appropriate treatment, leading to a higher burden of disease in the region.Additionally, cultural beliefs and practices surrounding mental illness can also impact the market. In some African societies, mental illness is still stigmatized, leading to underreporting and underdiagnosis of psychotic disorders. This can hinder the growth of the market as individuals may be hesitant to seek help or disclose their symptoms.

    Underlying macroeconomic factors:
    Several macroeconomic factors contribute to the development of the Psychotic Disorders market in Africa. Economic growth and increasing disposable income in many countries have led to a greater ability to afford healthcare services, including treatment for mental illnesses. Additionally, improvements in healthcare infrastructure and the expansion of health insurance coverage have made mental health services more accessible to a larger population.Furthermore, the increasing prevalence of risk factors for psychotic disorders, such as substance abuse, trauma, and urbanization, also contribute to the growth of the market. These factors can increase the likelihood of developing psychotic disorders and drive the demand for treatment options.In conclusion, the Psychotic Disorders market in Africa is experiencing growth and development due to increasing customer preferences for treatment, such as antipsychotic medications and psychotherapy. However, there are also local special circumstances, such as limited availability of mental healthcare services and cultural beliefs surrounding mental illness, that influence the market. Underlying macroeconomic factors, including economic growth and the increasing prevalence of risk factors, also contribute to the development of the market.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

    Modeling approach / Market size:

    Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

    Additional Notes:

    The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

    Health

    Access more Market Insights on Health topics with our featured report

    Psychotic Disorders: market data & analysis - BackgroundPsychotic Disorders: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    U.S. Mental Health Issues - Statistics & Facts

    Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.